Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AVTXAvalo Therapeutics, Inc.

Nasdaq · CIK 0001534120
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts439

Identity from submissions API

NameAvalo Therapeutics, Inc.
CIK0001534120
TickersAVTX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN450705648
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone410-522-8707
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • Cerecor Inc. (2012-04-04T04:00:00.000Z → 2021-08-18T04:00:00.000Z)
Business address
1500 LIBERTY RIDGE DRIVE
SUITE 321
WAYNE
PA
19087
PA
Mailing address
1500 LIBERTY RIDGE DRIVE
SUITE 321
WAYNE
PA
19087
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1225 filing rows loaded from submissions recent; extra archives: CIK0001534120-submissions-001.json (225 filings, 2012-04-04 to 2017-05-10).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-003170 005-89290 261560704 34 23131
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-008106 005-89290 261560687 34 12461
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000525 005-89290 261549254 34 32927
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000620 005-89290 261537809 34 8160
2026-11-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002939 005-89290 261529767 34 11552
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002679 005-89290 261526098 34 11748
2026-11-05 8-K FORM 8-K 1.01,1.02,9.01 0001104659-26-123079 001-37590 261524922 34 501164 1 1
2026-11-05 S-3ASR S-3ASR 0001104659-26-123072 333-299835 261524877 33 1485560 1 1
2026-11-05 424B5 424B5 0001104659-26-123069 333-292614 261524864 33 717655
2026-11-05 10-Q 10-Q 0001534120-26-000057 001-37590 261524700 34 8067565 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001534120-26-000056 001-37590 261524673 34 420664 1 1
2026-10-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-049273 005-89290 261502000 34 24135
2026-10-02 4 xslF345X06/form4-10022026_041020.xml 0001707797-26-000017 5819
2026-10-02 4 xslF345X06/form4-10022026_041018.xml 0001677036-26-000009 5834
2026-10-02 4 xslF345X06/form4-10022026_041016.xml 0002063957-26-000009 5775
2026-09-18 4 xslF345X06/form4-09182026_040901.xml 0001810417-26-000023 9350
2026-09-11 4 xslF345X06/form4-09112026_040901.xml 0001810417-26-000021 9439
2026-09-01 4 xslF345X06/form4-09012026_080946.xml 0001918845-26-000031 9042
2026-08-19 4 xslF345X06/form4-08192026_040813.xml 0001810417-26-000019 20349
2026-08-19 4 xslF345X06/form4-08192026_040810.xml 0001918845-26-000029 9045
2026-08-18 144 xsl144X01/primary_doc.xml 0001950047-26-008317 001-37590 261290931 33 6259
2026-08-17 144 xsl144X01/primary_doc.xml 0001950047-26-008276 001-37590 261287350 33 8712
2026-08-17 144 xsl144X01/primary_doc.xml 0001950047-26-008273 001-37590 261287324 33 5132
2026-08-17 144 xsl144X01/primary_doc.xml 0001950047-26-008220 001-37590 261286885 33 8601
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097285 005-89290 261282970 34 11081
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001727492-26-000021 005-89290 261282941 34 10032
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001231919-26-000918 005-89290 261282900 34 14898
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-002164 005-89290 261280918 34 25348
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000606 005-89290 261277507 34 7844
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-003460 005-89290 261276574 34 10726
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003475 005-89290 261276354 34 11485
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001011438-26-000509 005-89290 261273271 34 9314
2026-08-12 4 xslF345X06/form4-08122026_040809.xml 0002047607-26-000008 5361
2026-08-12 4 xslF345X06/form4-08122026_040801.xml 0001918845-26-000026 9042
2026-08-11 144 xsl144X01/primary_doc.xml 0001950047-26-007948 001-37590 261263596 33 4850
2026-08-10 144 xsl144X01/primary_doc.xml 0001950047-26-007908 001-37590 261259200 33 8481
2026-08-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002249 005-89290 261252376 34 11744
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000415 005-89290 261251581 34 8107
2026-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001940 005-89290 261246894 34 11741
2026-08-06 10-Q 10-Q 0001534120-26-000049 001-37590 261245889 34 8287522 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001534120-26-000048 001-37590 261245870 34 431126 1 1
2026-07-29 4 xslF345X06/form4-07292026_040701.xml 0001918845-26-000024 9045
2026-07-28 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002480 333-297528 261213711 33 1849
2026-07-28 424B3 424B3 0001104659-26-087573 333-297528 261212440 33 273081
2026-07-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002194 005-89290 261206086 34 10931
2026-07-17 S-3 S-3 0001104659-26-084609 333-297528 261183694 33 532169 1 1
2026-07-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-080836 005-89290 261157030 34 15845
2026-07-02 4 xslF345X06/form4-07022026_040722.xml 0001918845-26-000022 12987
2026-07-02 4 xslF345X06/form4-07022026_040721.xml 0002063957-26-000007 5528
2026-07-02 4 xslF345X06/form4-07022026_040719.xml 0001677036-26-000006 5593
2026-07-02 4 xslF345X06/form4-07022026_040717.xml 0001707797-26-000014 5578
2026-06-25 4 xslF345X06/form4-06252026_090648.xml 0001918845-26-000020 9046
2026-06-25 4 xslF345X06/form4-06252026_090620.xml 0002063957-26-000005 5686
2026-06-25 3 xslF345X06/form3-06252026_090639.xml 0002063957-26-000004 37435
2026-06-23 8-K 8-K 5.02 0001534120-26-000044 001-37590 261108896 34 166545 1 1
2026-06-18 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000029 005-89290 261103158 34 15986
2026-06-16 8-K 8-K 8.01,9.01 0001534120-26-000042 001-37590 261092874 34 5604134 1 1
2026-06-12 4 xslF345X06/form4-06122026_080614.xml 0002047607-26-000006 5067
2026-06-12 4 xslF345X06/form4-06122026_080618.xml 0001677896-26-000008 5061
2026-06-12 4 xslF345X06/form4-06122026_080641.xml 0001810417-26-000016 5061
2026-06-12 4 xslF345X06/form4-06122026_080645.xml 0001918845-26-000018 5084
2026-06-12 8-K 8-K 3.02,3.03,5.02,5.03,9.01 0001534120-26-000040 001-37590 261086659 34 770234 1 1
2026-06-08 8-K 8-K 5.02,5.07,9.01 0001534120-26-000036 001-37590 261072898 34 291542 1 1
2026-06-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001408 005-89290 261067315 34 11608
2026-06-04 4 xslF345X06/form4-06042026_040609.xml 0001677036-26-000004 5669
2026-06-04 4 xslF345X06/form4-06042026_040611.xml 0002017156-26-000004 5665
2026-06-04 4 xslF345X06/form4-06042026_040607.xml 0001247024-26-000004 5756
2026-06-04 4 xslF345X06/form4-06042026_040605.xml 0001862734-26-000004 5618
2026-06-04 4 xslF345X06/form4-06042026_040603.xml 0001448914-26-000004 5689
2026-06-04 4 xslF345X06/form4-06042026_040601.xml 0001707797-26-000008 5654
2026-06-02 144 xsl144X01/primary_doc.xml 0001950047-26-005476 001-37590 261056025 33 6672
2026-06-01 4 xslF345X06/form4-06012026_040618.xml 0001918845-26-000016 9042
2026-05-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002447 005-89290 261045313 34 11360
2026-05-26 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003702 005-89290 261021018 34 17682
2026-05-26 4 xslF345X06/form4-05262026_040508.xml 0002047607-26-000004 5443
2026-05-26 4 xslF345X06/form4-05262026_040507.xml 0001810417-26-000014 5439
2026-05-26 4 xslF345X06/form4-05262026_040505.xml 0001677896-26-000006 5436
2026-05-26 4 xslF345X06/form4-05262026_040503.xml 0001918845-26-000014 5459
2026-05-26 4 xslF345X06/form4-05262026_040501.xml 0001586785-26-000006 5455
2026-05-19 4 xslF345X06/form4-05192026_040503.xml 0001918845-26-000012 9045
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000935836-26-000282 005-89290 26990256 34 21702
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000147 005-89290 26988702 34 15447
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000947871-26-000548 005-89290 26988589 34 7569
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-001385 005-89290 26986906 34 25558
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001727492-26-000008 005-89290 26983709 34 10144
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000487 005-89290 26983400 34 7675
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-002462 005-89290 26982475 34 14514
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001011438-26-000312 005-89290 26978920 34 9336
2026-05-13 10-Q 10-Q 0001534120-26-000033 001-37590 26970879 34 6734781 1 1
2026-05-13 8-K 8-K 2.02,9.01 0001534120-26-000032 001-37590 26970870 34 407027 1 1
2026-05-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-220002 005-89290 26970213 34 14627
2026-05-11 4 xslF345X06/form4-05112026_040503.xml 0001810417-26-000012 9375
2026-05-07 144 xsl144X01/primary_doc.xml 0001950047-26-004199 001-37590 26953768 33 8531
2026-05-07 4 xslF345X06/form4-05072026_080504.xml 0001677896-26-000004 20831
2026-05-07 4 xslF345X06/form4-05072026_080542.xml 0001810417-26-000010 17255
2026-05-07 4 xslF345X06/form4-05072026_080500.xml 0001918845-26-000010 29619
2026-05-07 4 xslF345X06/form4-05072026_080503.xml 0001789335-26-000006 5067
2026-05-07 8-K FORM 8-K 1.01,2.02,7.01,9.01 0001104659-26-056482 001-37590 26950255 34 666130 1 1
2026-05-07 424B5 424B5 0001104659-26-056481 333-292614 26950249 33 662343
2026-05-06 144 xsl144X01/primary_doc.xml 0001950047-26-004154 001-37590 26949434 33 7998
2026-05-06 144 xsl144X01/primary_doc.xml 0001950047-26-004142 001-37590 26949063 33 7802
2026-05-06 144 xsl144X01/primary_doc.xml 0001950047-26-004140 001-37590 26949026 33 5099
2026-05-06 144 xsl144X01/primary_doc.xml 0001950047-26-004138 001-37590 26948974 33 4874
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001098 005-89290 26946555 34 11370
2026-05-05 424B5 424B5 0001104659-26-055665 333-292614 26943716 33 661739
2026-05-05 8-K 8-K 8.01,9.01 0001534120-26-000028 001-37590 26942842 34 4258110 1 1
2026-05-01 4 xslF345X06/form4-05012026_080546.xml 0001810417-26-000008 7464
2026-04-29 144 xsl144X01/primary_doc.xml 0001950047-26-003835 001-37590 26916888 33 6342
2026-04-28 8-K 8-K 1.01,7.01,9.01 0001534120-26-000026 001-37590 26903081 34 388501 1 1
2026-04-10 ARS ARS 0001534120-26-000024 001-37590 26854812 34 25713125
2026-04-10 DEFA14A DEFA14A 0001534120-26-000023 001-37590 26854791 34 375059
2026-04-10 DEF 14A DEF 14A 0001534120-26-000022 001-37590 26854758 34 2523090 1 1
2026-04-08 4 xslF345X06/form4-04082026_080437.xml 0001918845-26-000008 9483
2026-04-06 144 xsl144X01/primary_doc.xml 0001950047-26-003276 001-37590 26841700 33 6559
2026-04-03 4 xslF345X06/form4-04032026_070439.xml 0001810417-26-000006 11363
2026-04-03 4 xslF345X06/form4-04032026_070418.xml 0001918845-26-000006 9039
2026-04-01 144 xsl144X01/primary_doc.xml 0001950047-26-003175 001-37590 26829098 33 4884
2026-04-01 4 xslF345X06/form4-04012026_040410.xml 0001707797-26-000003 5578
2026-04-01 4 xslF345X06/form4-04012026_040408.xml 0001677036-26-000002 5593
2026-04-01 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000935836-26-000188 005-89290 26826563 34 21561
2026-03-31 4 xslF345X06/form4-03312026_080309.xml 0002017156-26-000002 7323
2026-03-31 4 xslF345X06/form4-03312026_080342.xml 0001862734-26-000002 7276
2026-03-31 4 xslF345X06/form4-03312026_080359.xml 0001247024-26-000002 7414
2026-03-31 4 xslF345X06/form4-03312026_080315.xml 0001586785-26-000004 8836
2026-03-31 4 xslF345X06/form4-03312026_080330.xml 0001810417-26-000004 8837
2026-03-31 4 xslF345X06/form4-03312026_080349.xml 0001789335-26-000004 7328
2026-03-31 4 xslF345X06/form4-03312026_080309.xml 0002013869-26-000002 7297
2026-03-27 8-K 8-K 5.02 0001534120-26-000016 001-37590 26807107 34 161964 1 1
2026-03-23 S-8 FORM S-8 0001104659-26-032997 333-294513 26779879 33 210445 1 1
2026-03-23 10-K 10-K 0001534120-26-000011 001-37590 26779869 34 10852384 1 1
2026-03-23 8-K 8-K 2.02,9.01 0001534120-26-000010 001-37590 26779868 34 419004 1 1
2026-03-18 4 xslF345X06/form4-03182026_080310.xml 0001918845-26-000004 12984
2026-03-16 144 xsl144X01/primary_doc.xml 0001950047-26-002672 001-37590 26757432 33 5121
2026-03-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000651 005-89290 26728932 34 11542
2026-03-02 4 xslF345X05/form4-03022026_090313.xml 0001677896-26-000002 5639
2026-03-02 4 xslF345X05/form4-03022026_090329.xml 0002047607-26-000002 5646
2026-03-02 4 xslF345X05/form4-03022026_090303.xml 0001918845-26-000002 5665
2026-03-02 4 xslF345X05/form4-03022026_090334.xml 0002090172-26-000002 5644
2026-03-02 4 xslF345X05/form4-03022026_090301.xml 0001810417-26-000002 5645
2026-03-02 4 xslF345X05/form4-03022026_090353.xml 0001586785-26-000002 5659
2026-02-24 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-019185 005-89290 26672528 34 15280
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000947871-26-000187 005-89290 26644129 34 7409
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001727492-26-000006 005-89290 26643222 34 9953
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001147 005-89290 26642342 34 12045
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001346824-26-000035 005-89290 26641785 34 15336
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-016415 005-89290 26641319 34 15588
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-26-000454 005-89290 26641067 34 25720
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-052938 005-89290 26636222 34 149465
2026-02-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-012613 005-89290 26615976 34 15839
2026-02-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-012459 005-89290 26614413 34 8243
2026-02-03 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-009818 005-89290 26594537 34 15585
2026-01-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000048 005-89290 26581857 34 7160
2026-01-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001315863-26-000095 005-89290 26579975 34 15369
2026-01-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000222 333-292614 26544696 33 1848
2026-01-15 CORRESP filename1.htm 0001104659-26-003896 8272
2026-01-14 UPLOAD filename1.pdf 0000000000-26-000493 333-292614 40141
2026-01-12 8-K 8-K 2.02,8.01 0001534120-26-000003 001-37590 26524700 34 3775971 1 1
2026-01-08 S-3 S-3 0001104659-26-002118 333-292614 26519559 33 1006811 1 1
2026-01-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001470831-26-000007 5267
2026-01-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001470831-26-000006 5255
2025-12-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001470831-25-000412 4804
2025-12-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001470831-25-000411 4787
2025-12-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001470831-25-000410 4781
2025-12-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001470831-25-000409 4789
2025-12-02 8-K 8-K 8.01 0001534120-25-000022 001-37590 251541540 34 3783728 1 1
2025-11-17 4 PRIMARY DOCUMENT 0002013869-25-000002 10330
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-283440 005-89290 251488668 34 14045
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112690 005-89290 251487789 34 11321
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001231919-25-000484 005-89290 251486259 34 15337
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-005012 005-89290 251486219 34 12169
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-003090 005-89290 251485473 34 25765
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004971 005-89290 251484617 34 14579
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112178 005-89290 251483656 34 10196
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-004822 005-89290 251481363 34 11387
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-281204 005-89290 251480789 34 126170
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001999371-25-017697 005-89290 251479816 34 9505
2025-11-06 S-8 S-8 0001534120-25-000020 333-291304 251456112 33 240555 1 1
2025-11-06 10-Q 10-Q 0001534120-25-000018 001-37590 251456089 34 8291810 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001534120-25-000017 001-37590 251456073 34 443206 1 1
2025-10-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000035 005-89290 251433990 34 6261
2025-10-29 8-K 8-K 8.01,9.01 0001534120-25-000013 001-37590 251426788 34 195595 1 1
2025-10-10 8-K 8-K 8.01,9.01 0001534120-25-000011 001-37590 251386271 34 3770710 1 1
2025-10-06 4 PRIMARY DOCUMENT 0002090172-25-000002 5723
2025-10-06 3 PRIMARY DOCUMENT 0002090172-25-000001 7184
2025-10-02 4 PRIMARY DOCUMENT 0001677036-25-000004 5533
2025-10-02 3 PRIMARY DOCUMENT 0001677036-25-000003 7088
2025-10-02 4 PRIMARY DOCUMENT 0001707797-25-000006 5374
2025-10-01 8-K 8-K 5.02,8.01,9.01 0001534120-25-000009 001-37590 251362539 34 321687 1 1
2025-09-22 8-K 8-K 5.02,9.01 0001534120-25-000005 001-37590 251328377 34 207613 1 1
2025-08-27 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-025721 005-89290 251266265 34 6879
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000947871-25-000779 005-89290 251221485 34 15229
2025-08-07 10-Q 10-Q 0001628280-25-038575 001-37590 251191525 34 7893491 1 1
2025-08-07 8-K 8-K 2.02,9.01 0001628280-25-038570 001-37590 251191510 34 446199 1 1
2025-08-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003367 005-89290 251185927 34 18065
2025-06-20 8-K 8-K 8.01,9.01 0001628280-25-032232 001-37590 251059063 34 3735767 1 1
2025-06-18 4 PRIMARY DOCUMENT 0001578563-25-000325 5468
2025-06-18 4 PRIMARY DOCUMENT 0001578563-25-000324 5473
2025-06-18 4 PRIMARY DOCUMENT 0001578563-25-000323 5442
2025-06-18 4 PRIMARY DOCUMENT 0001578563-25-000322 5536
2025-06-18 4 PRIMARY DOCUMENT 0001578563-25-000321 5421
2025-06-18 4 PRIMARY DOCUMENT 0001578563-25-000320 5497
2025-06-18 4 PRIMARY DOCUMENT 0001578563-25-000319 5484
2025-06-18 4 PRIMARY DOCUMENT 0001578563-25-000318 5517
2025-06-18 3 PRIMARY DOCUMENT 0001578563-25-000317 6305
2025-06-18 8-K 8-K 5.02,8.01,9.01 0001628280-25-032011 001-37590 251055112 34 229021 1 1
2025-06-17 8-K 8-K 5.07 0001628280-25-031818 001-37590 251053239 34 184860 1 1
2025-06-05 8-K 8-K 1.01,1.02,9.01 0001628280-25-029639 001-37590 251027194 34 527831 1 1
2025-06-05 424B5 424B5 0001628280-25-029637 333-271225 251027170 33 695189
2025-06-04 8-K 8-K 8.01,9.01 0001628280-25-029225 001-37590 251021878 34 4221480 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072881 005-89290 25956073 34 13619
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-013180 005-89290 25954853 34 19719
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049515 005-89290 25954364 34 10757
2025-05-12 S-8 S-8 0001628280-25-024441 333-287176 25932570 33 97693
2025-05-12 S-8 S-8 0001628280-25-024440 333-287175 25932562 33 98944
2025-05-12 10-Q 10-Q 0001628280-25-024436 001-37590 25932542 34 7087613 1 1
2025-05-12 8-K 8-K 2.02,9.01 0001628280-25-024435 001-37590 25932538 34 426439 1 1
2025-05-08 8-K 8-K 8.01,9.01 0001628280-25-023442 001-37590 25923795 34 4240129 1 1
2025-05-01 ARS ARS 0001628280-25-021315 001-37590 25899352 34 22997021
2025-05-01 DEFA14A DEFA14A 0001628280-25-021313 001-37590 25899345 34 382229
2025-05-01 DEF 14A DEF 14A 0001628280-25-021311 001-37590 25899335 34 2308388 1 1
2025-04-01 4 PRIMARY DOCUMENT 0001578563-25-000204 7154
2025-04-01 4 PRIMARY DOCUMENT 0001578563-25-000203 7093
2025-04-01 4 PRIMARY DOCUMENT 0001578563-25-000202 7149
2025-04-01 4 PRIMARY DOCUMENT 0001578563-25-000201 7165
2025-04-01 4 PRIMARY DOCUMENT 0001578563-25-000200 7217
2025-04-01 4 PRIMARY DOCUMENT 0001578563-25-000199 8087
2025-04-01 4 PRIMARY DOCUMENT 0001578563-25-000198 8700
2025-04-01 4 PRIMARY DOCUMENT 0001578563-25-000197 8675
2025-03-26 4 PRIMARY DOCUMENT 0001578563-25-000193 5551
2025-03-26 3 PRIMARY DOCUMENT 0001578563-25-000192 6355
2025-03-26 8-K 8-K 5.02,8.01,9.01 0001628280-25-014833 001-37590 25770093 34 206774 1 1
2025-03-20 10-K 10-K 0001628280-25-013986 001-37590 25754471 34 11085768 1 1
2025-03-20 8-K 8-K 2.02,9.01 0001628280-25-013984 001-37590 25754462 34 395840 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-000466 005-89290 25628109 34 25625
2025-01-30 4 PRIMARY DOCUMENT 0001578563-25-000029 5567
2025-01-30 4 PRIMARY DOCUMENT 0001578563-25-000028 5630
2025-01-30 4 PRIMARY DOCUMENT 0001578563-25-000027 5608
2025-01-30 4 PRIMARY DOCUMENT 0001578563-25-000026 5632
2025-01-13 8-K 8-K 8.01,9.01 0001628280-25-001228 001-37590 25524772 34 4194432 1 1
2025-01-03 4 PRIMARY DOCUMENT 0001578563-25-000002 5650
2025-01-03 3 PRIMARY DOCUMENT 0001578563-25-000001 6396
2025-01-02 8-K 8-K 5.02,8.01,9.01 0001628280-25-000005 001-37590 25500208 34 314125 1 1
2024-12-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001999371-24-015946 005-89290 241593158 34 8828
2024-12-05 8-K 8-K 8.01,9.01 0001628280-24-049979 001-37590 241527809 34 4145229 1 1
2024-11-14 SC 13G SCHEDULE 13G 0000947871-24-000909 005-89290 241464970 34 68979
2024-11-14 4 PRIMARY DOCUMENT 0001578563-24-000441 7082
2024-11-14 SC 13G/A avalo13ga1-11142024.htm 0001013594-24-000957 005-89290 241459174 34 136679
2024-11-12 8-K 8-K 8.01,9.01 0001628280-24-046852 001-37590 241443303 34 4142048 1 1
2024-11-07 SC 13G/A formsc13ga.htm 0001493152-24-044038 005-89290 241436873 34 67819
2024-11-07 S-8 S-8 0001628280-24-045983 333-283048 241433166 33 114092
2024-11-07 S-8 S-8 0001628280-24-045982 333-283047 241433158 33 122099
2024-11-07 10-Q 10-Q 0001628280-24-045965 001-37590 241433084 34 8088533 1 1
2024-11-07 8-K 8-K 2.02,9.01 0001628280-24-045964 001-37590 241433072 34 418739 1 1
2024-10-08 8-K 8-K 8.01,9.01 0001628280-24-042478 001-37590 241359175 34 4229086 1 1
2024-10-07 SC 13G SC 13G 0001193125-24-234002 005-89290 241358952 34 66589
2024-09-09 8-K 8-K 8.01,9.01 0001628280-24-039764 001-37590 241285853 34 3576486 1 1
2024-09-04 8-K 8-K 8.01 0001628280-24-039221 001-37590 241275839 34 143039 1 1
2024-08-23 SC 13G THE SCHEDULE 13G 0000921895-24-001924 005-89290 241236758 34 290741
2024-08-23 SC 13G SC 13G 0001104659-24-092443 005-89290 241236554 34 106101
2024-08-23 SC 13G formsc13g.htm 0001493152-24-033701 005-89290 241236281 34 72288
2024-08-14 4 PRIMARY DOCUMENT 0001578563-24-000370 7902
2024-08-14 4 PRIMARY DOCUMENT 0001578563-24-000369 7933
2024-08-14 4 PRIMARY DOCUMENT 0001578563-24-000368 7955
2024-08-14 4 PRIMARY DOCUMENT 0001578563-24-000367 7944
2024-08-14 4 PRIMARY DOCUMENT 0001578563-24-000366 7928
2024-08-14 4 PRIMARY DOCUMENT 0001578563-24-000365 7996
2024-08-14 4 PRIMARY DOCUMENT 0001578563-24-000364 8781
2024-08-14 8-K 8-K 5.02,5.07,9.01 0001628280-24-037174 001-37590 241207281 34 501819 1 1
2024-08-14 4 PRIMARY DOCUMENT 0001578563-24-000363 8763
2024-08-12 10-Q 10-Q 0001628280-24-036591 001-37590 241194703 34 7390007 1 1
2024-08-12 8-K 8-K 2.02,9.01 0001628280-24-036589 001-37590 241194696 34 414683 1 1
2024-08-06 UPLOAD filename1.pdf 0000000000-24-008978 001-37590 39884
2024-08-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-08-05 16:00:00 9999999995-24-002408 333-279992 241176846 33 1848
2024-08-05 424B3 424B3 0001628280-24-034770 333-279992 241175359 33 825420
2024-08-01 CORRESP filename1.htm 0001628280-24-034108 149186
2024-07-30 8-K 8-K 8.01 0001628280-24-033437 001-37590 241157252 34 144395 1 1
2024-07-29 CORRESP filename1.htm 0001628280-24-033291 23241
2024-07-29 S-3/A S-3/A 0001628280-24-033278 333-279992 241152420 33 922999
2024-07-24 UPLOAD filename1.pdf 0000000000-24-008406 333-279992 43326
2024-07-16 4 PRIMARY DOCUMENT 0001578563-24-000331 5666
2024-07-16 3 PRIMARY DOCUMENT 0001578563-24-000330 6400
2024-07-16 8-K 8-K 5.02,8.01,9.01 0001628280-24-031923 001-37590 241118591 34 303639 1 1
2024-07-11 CORRESP filename1.htm 0001628280-24-031701 24366
2024-07-11 CORRESP filename1.htm 0001628280-24-031699 53786
2024-07-11 S-3/A S-3/A 0001628280-24-031696 333-279992 241112316 33 926724
2024-07-11 10-Q/A 10-Q/A 0001628280-24-031693 001-37590 241112188 34 7032366 1 1
2024-07-09 8-K 8-K 8.01,9.01 0001628280-24-031426 001-37590 241106328 34 177801 1 1
2024-07-02 UPLOAD filename1.pdf 0000000000-24-007554 001-37590 58095
2024-07-02 UPLOAD filename1.pdf 0000000000-24-007553 333-279992 44734
2024-06-27 ARS ARS 0001628280-24-030234 001-37590 241075358 34 21300292
2024-06-27 DEFA14A DEFA14A 0001628280-24-030233 001-37590 241075294 34 440999
2024-06-27 DEF 14A DEF 14A 0001628280-24-030232 001-37590 241075291 34 4348256
2024-06-25 4 PRIMARY DOCUMENT 0001578563-24-000320 5643
2024-06-25 3 PRIMARY DOCUMENT 0001578563-24-000319 6328
2024-06-24 8-K 8-K 5.02,8.01,9.01 0001628280-24-029564 001-37590 241064225 34 311927 1 1
2024-06-24 8-K/A 8-K/A 9.01 0001628280-24-029561 001-37590 241064201 34 510596 1 1
2024-06-24 8-K 8-K 8.01,9.01 0001628280-24-029428 001-37590 241061965 34 4215319 1 1
2024-06-07 PRE 14A PRE 14A 0001628280-24-027164 001-37590 241027254 34 4363574
2024-06-06 S-3 S-3 0001628280-24-027025 333-279992 241024962 33 1319095
2024-06-03 8-K/A 8-K/A 9.01 0001628280-24-026140 001-37590 241011982 34 457780 1 1
2024-05-23 8-K 8-K 3.01 0001628280-24-024920 001-37590 24978017 34 145695 1 1
2024-05-13 SC 13G avalo13g-05132024.htm 0001013594-24-000465 005-89290 24937895 34 135218
2024-05-13 10-Q 10-Q 0001628280-24-022763 001-37590 24936887 34 7792221 1 1
2024-05-13 8-K 8-K 2.02,9.01 0001628280-24-022762 001-37590 24936881 34 386119 1 1
2024-04-23 SC 13G emerald13g.htm 0001123292-24-000115 005-89290 24864297 34 251578
2024-04-09 D xslFormDX01/primary_doc.xml 06b 0001578563-24-000186 021-510110 24833374 33 14260
2024-04-05 SC 13G deeptrack-avtx032724.htm 0001172661-24-001737 005-89290 24826385 34 105949
2024-04-03 3 PRIMARY DOCUMENT 0001578563-24-000185 6315
2024-04-03 3 PRIMARY DOCUMENT 0001578563-24-000184 6270
2024-04-03 3 PRIMARY DOCUMENT 0001578563-24-000183 6332
2024-03-29 10-K 10-K 0001628280-24-013786 001-37590 24804123 34 10047904 1 1
2024-03-29 8-K 8-K 2.02,9.01 0001628280-24-013783 001-37590 24804103 34 389195 1 1
2024-03-28 DEFA14A DEFA14A 0001628280-24-013442 001-37590 24793327 34 71985
2024-03-28 8-K 8-K 1.01,2.01,3.01,3.02,5.02,5.03,8.01,9.01 0001628280-24-013435 001-37590 24793277 34 5979252 1 1
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024255 005-89290 24641766 34 140425
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023903 005-89290 24639804 34 70966
2024-02-14 SC 13G/A greatpoint-avtx123123a1.htm 0001172661-24-001522 005-89290 24639359 34 118505
2024-02-14 SC 13G/A AVALO THERAPEUTICS, INC. 0000902664-24-001630 005-89290 24633419 34 72284
2024-01-31 8-K 8-K 8.01 0001628280-24-002715 001-37590 24582796 34 148600 1 1
2023-12-28 8-K 8-K 3.03,5.03,9.01 0001628280-23-042817 001-37590 231523382 34 209278 1 1
2023-12-21 4 FORM 4 0001628280-23-042493 5428
2023-12-21 4 FORM 4 0001628280-23-042492 5479
2023-12-21 4 FORM 4 0001628280-23-042491 5520
2023-12-21 4 FORM 4 0001628280-23-042490 5457
2023-12-20 8-K 8-K 5.07 0001628280-23-042223 001-37590 231501336 34 166552 1 1
2023-12-07 DEFA14A DEFA14A 0001628280-23-040981 001-37590 231471056 34 57252
2023-12-07 8-K 8-K 8.01,9.01 0001628280-23-040980 001-37590 231471053 34 188410 1 1
2023-11-16 8-K 8-K 3.01 0001628280-23-039211 001-37590 231412403 34 154242 1 1
2023-11-09 10-Q 10-Q 0001628280-23-038036 001-37590 231390053 34 6166360 1 1
2023-11-09 8-K 8-K 2.02,9.01 0001628280-23-038030 001-37590 231390005 34 405919 1 1
2023-10-31 8-K 8-K 2.01,8.01,9.01 0001628280-23-035600 001-37590 231362286 34 308057 1 1
2023-10-19 ARS ARS 0001628280-23-034696 001-37590 231334875 34 2217632
2023-10-19 DEFA14A DEFA14A 0001628280-23-034690 001-37590 231334802 34 388170
2023-10-19 DEF 14A DEF 14A 0001628280-23-034686 001-37590 231334753 34 1613276
2023-10-17 8-K 8-K 5.03,9.01 0001628280-23-034510 001-37590 231329628 34 330959 1 1
2023-10-05 PRE 14A PRE 14A 0001628280-23-033960 001-37590 231311323 34 1609745
2023-10-03 8-K 8-K 5.08 0001628280-23-033629 001-37590 231303524 34 150726 1 1
2023-09-26 8-K 8-K 1.01,8.01,9.01 0001628280-23-032984 001-37590 231277153 34 412732 1 1
2023-09-13 8-K 8-K 1.01,9.01 0001628280-23-032187 001-37590 231252683 34 303441 1 1
2023-09-13 8-K 8-K 3.01,8.01 0001628280-23-032140 001-37590 231251697 34 158086 1 1
2023-09-12 8-K 8-K 1.01,7.01,9.01 0001628280-23-032021 001-37590 231249000 34 639757 1 1
2023-09-11 8-K 8-K 8.01,9.01 0001628280-23-031924 001-37590 231246693 34 4128734 1 1
2023-08-14 8-K 8-K 1.01,8.01,9.01 0001628280-23-029393 001-37590 231170688 34 223833 1 1
2023-08-08 8-K 8-K 3.01 0001628280-23-028192 001-37590 231151429 34 150740 1 1
2023-08-07 8-K 8-K 1.01,9.01 0001628280-23-027842 001-37590 231148628 34 190790 1 1
2023-08-07 424B5 424B5 0001628280-23-027841 333-271225 231148621 33 77050
2023-08-03 10-Q 10-Q 0001628280-23-026990 001-37590 231138006 34 7809469 1 1
2023-08-03 8-K 8-K 2.02,9.01 0001628280-23-026988 001-37590 231137994 34 410232 1 1
2023-07-21 8-K 8-K 1.01,2.04,8.01,9.01 0001628280-23-025293 001-37590 231101142 34 4696942 1 1
2023-07-05 4 FORM 4 0001628280-23-024232 5298
2023-07-05 4 FORM 4 0001628280-23-024230 5349
2023-06-29 SC 13G/A g13.txt 0001929354-23-000017 005-89290 231054378 34 8006
2023-06-28 4 FORM 4 SUBMISSION 0000899243-23-016659 12168
2023-06-28 SC 13D/A form_sc13da-avalo.htm 0001011438-23-000425 005-89290 231048706 34 62792
2023-06-27 4 PRIMARY DOCUMENT 0001929354-23-000016 6969
2023-06-26 8-K 8-K 8.01,9.01 0001628280-23-023374 001-37590 231039408 34 314483 1 1
2023-06-20 4 PRIMARY DOCUMENT 0001929354-23-000015 9842
2023-06-14 4 PRIMARY DOCUMENT 0001929354-23-000014 9841
2023-06-13 4 FORM 4 0001628280-23-021962 4748
2023-06-13 4 FORM 4 0001628280-23-021958 4761
2023-06-09 4 PRIMARY DOCUMENT 0001929354-23-000013 9840
2023-06-02 4 PRIMARY DOCUMENT 0001929354-23-000012 5835
2023-06-02 8-K 8-K 1.01,3.02,9.01 0001628280-23-020611 001-37590 23986737 34 342562 1 1
2023-05-30 4 PRIMARY DOCUMENT 0001929354-23-000011 7714
2023-05-24 4 PRIMARY DOCUMENT 0001929354-23-000010 7959
2023-05-22 4 PRIMARY DOCUMENT 0001929354-23-000009 9838
2023-05-17 4 FORM 4 0001628280-23-018557 5440
2023-05-17 4 FORM 4 0001628280-23-018556 5451
2023-05-16 4 PRIMARY DOCUMENT 0001929354-23-000008 9351
2023-05-08 4 PRIMARY DOCUMENT 0001929354-23-000007 9840
2023-05-04 S-8 S-8 0001628280-23-015818 333-271655 23889916 33 92353
2023-05-04 424B5 424B5 0001628280-23-015810 333-271225 23889831 33 1143143
2023-05-04 8-K 8-K 1.01,9.01 0001628280-23-015804 001-37590 23889740 34 530498 1 1
2023-05-04 10-Q 10-Q 0001628280-23-015703 001-37590 23888565 34 7255219 1 1
2023-05-04 8-K 8-K 2.02,9.01 0001628280-23-015695 001-37590 23888506 34 406155 1 1
2023-05-02 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-05-02 16:15:00 9999999995-23-001236 333-271225 23881488 33 1798
2023-04-28 CORRESP filename1.htm 0001628280-23-014165 223795
2023-04-27 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001628280-23-012931,2023-04-27 9999999995-23-001063 333-254000 23859791 33 1811
2023-04-27 4 PRIMARY DOCUMENT 0001929354-23-000006 9593
2023-04-25 POS AM POS AM 0001628280-23-012931 333-254000 23844954 33 29407
2023-04-24 4 PRIMARY DOCUMENT 0001929354-23-000005 7961
2023-04-21 8-K 8-K 1.02 0001628280-23-012415 001-37590 23836308 34 164611 1 1
2023-04-19 SC 13G/A G13A4.txt 0001929354-23-000004 005-89290 23830447 34 8329
2023-04-18 4 PRIMARY DOCUMENT 0001929354-23-000003 7961
2023-04-13 UPLOAD filename1.pdf 0000000000-23-003709 40319
2023-04-12 S-3 S-3 0001628280-23-011384 333-271225 23815643 33 770470
2023-04-11 4 PRIMARY DOCUMENT 0001929354-23-000002 7963
2023-04-04 4 FORM 4 0001628280-23-010589 5428
2023-04-04 4 FORM 4 0001628280-23-010578 5377
2023-03-29 10-K 10-K 0001628280-23-009630 001-37590 23771777 34 10616600 1 1
2023-03-29 8-K 8-K 2.02,9.01 0001628280-23-009629 001-37590 23771774 34 413896 1 1
2023-03-13 8-K 8-K 7.01,9.01 0001628280-23-007632 001-37590 23725782 34 4932233 1 1
2023-02-17 SC 13G SC 13G 0001104659-23-023264 005-89290 23642440 34 215680
2023-02-15 4 FORM 4 0001628280-23-003708 5627
2023-02-15 4 FORM 4 0001628280-23-003706 5602
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021885 005-89290 23631092 34 69961
2023-02-14 SC 13G/A SCHEDULE 13G/A, AMENDMENT #2 0000899140-23-000400 005-89290 23629831 34 50075
2023-02-14 SC 13G/A G13A.txt 0001929354-23-000001 005-89290 23629215 34 8331
2023-02-13 SC 13G greatpoint-avtx020323.htm 0001172661-23-000756 005-89290 23618495 34 120164
2023-02-09 4 FORM 4 SUBMISSION 0000899243-23-004412 14199

Latest XBRL company facts

One latest value per concept from companyfacts (439 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 57.82M 2026-11-02 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
dei EntityPublicFloat Entity Public Float USD 53.70M 2025-06-30 2025 FY 10-K 2026-03-23 0001534120-26-000011
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 4.60M 2025-01-01 2025-12-31 DEF 14A 2026-04-10 0001534120-26-000022
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.50M 2025-01-01 2025-12-31 DEF 14A 2026-04-10 0001534120-26-000022
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 2 2025-01-01 2025-12-31 DEF 14A 2026-04-10 0001534120-26-000022
ffd NetFeeAmt NetFeeAmt USD 0 2026-10-30 S-3ASR 2026-11-05 0001104659-26-123072
ffd TtlFeeAmt TtlFeeAmt USD 0 2026-10-30 S-3ASR 2026-11-05 0001104659-26-123072
ffd TtlOfferingAmt TtlOfferingAmt USD 0 2026-10-30 S-3ASR 2026-11-05 0001104659-26-123072
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-30 S-3ASR 2026-11-05 0001104659-26-123072
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-30 S-3ASR 2026-11-05 0001104659-26-123072
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.46M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap AccountsReceivableBilledForLongTermContractsOrPrograms Construction Contractor, Receivable, Excluding Contract Retainage USD 208,204 2019-09-30 2019 Q3 10-Q 2019-11-14 0001628280-19-014207
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 0 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 38,000 2023-06-30 2023 Q2 10-Q 2023-08-03 0001628280-23-026990
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 21.64M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap AccruedMarketingCostsCurrent Accrued Marketing Costs, Current USD 92,000 2022-03-31 2022 Q1 10-Q 2022-05-05 0001628280-22-012436
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 132,163 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 961.46M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 94,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 14.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 1.75M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-03 0001628280-23-026990
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 3.64M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net USD -33,959 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001628280-19-014207
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 14.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001628280-24-013786
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap AssetAcquisitionContingentConsiderationLiabilityCurrent AssetAcquisitionContingentConsiderationLiabilityCurrent USD 5.00M 2024-09-30 2024 Q3 10-Q 2024-11-07 0001628280-24-045965
us-gaap Assets Assets USD 481.43M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap AssetsCurrent Assets, Current USD 400.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 432.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 74,000 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 6,000 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 6.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 0 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 0 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles USD 6,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt USD 0 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 64.99M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 133.15M 2024-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -2.66M 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 462.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 65.38M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -241,155 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001628280-18-010858
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 49.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.012 2021-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 4.00M 2018-12-31 2021 Q1 10-Q 2021-05-13 0001628280-21-010083
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 53.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 53.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap CommonStockValue Common Stock, Value, Issued USD 54,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -76.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap ContingentConsiderationClassifiedAsEquityFairValueDisclosure Contingent Consideration Classified as Equity, Fair Value Disclosure USD 0 2018-12-31 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap ContractsRevenue Contracts Revenue (Deprecated 2018-01-31) USD 222,656 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001628280-18-006658
us-gaap ContractualObligation Contractual Obligation USD 7.46M 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 0 2018-09-30 2018 Q3 10-Q 2018-11-13 0001628280-18-014190
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 0 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 4.26M 2018-12-31 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 4.27M 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 0 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 3.19M 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-29 0001628280-24-013786
us-gaap ContractWithCustomerReceivableAllowanceForCreditLoss Contract with Customer, Receivable, Allowance for Credit Loss USD 2.90M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001628280-21-010083
us-gaap ContractWithCustomerReceivableCreditLossExpenseReversal Contract with Customer, Receivable, Credit Loss Expense (Reversal) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001628280-24-013786
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 11.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001628280-25-038575
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 100,000 2018-02-16 2018-03-31 2018 Q2 10-Q 2018-08-09 0001628280-18-010858
us-gaap CostsAndExpenses Costs and Expenses USD 75.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001628280-17-002566
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 100,000 2012-03-01 2012-03-31 2015 FY 10-K 2016-03-23 0001558370-16-004299
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 0 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 0 2018-03-31 2018 Q1 10-Q 2018-05-11 0001628280-18-006658
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-04 0001628280-22-020866
us-gaap DebtLongtermAndShorttermCombinedAmount Debt, Long-term and Short-term, Combined Amount USD 0 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss USD 91.48M 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 362.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterest DebtSecuritiesAvailableForSaleExcludingAccruedInterest USD 91.55M 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 25,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 337,797 2020-06-30 2020 Q2 10-Q 2020-08-06 0001628280-20-011892
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 36,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.68M 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 470,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap DeferredRevenue Deferred Revenue USD 88,000 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 140,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 4.72M 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 65.39M 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 0 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.25M 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 61.74M 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 8.40M 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 7.67M 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 7.70M 2024-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 1.04M 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3.26M 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 15,373 2018-12-31 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 13,000 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 87.56M 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 434,000 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill Deferred Tax Liabilities, Goodwill USD 1.25M 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 286,000 2023-12-31 2023 FY 10-K 2024-03-29 0001628280-24-013786
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 342,000 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap Deposits Deposits USD 50,000 2016-12-31 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap Depreciation Depreciation USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 52,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral Derivative Liability, Fair Value, Amount Not Offset Against Collateral USD 100,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001628280-23-038036
us-gaap DerivativeLiabilities Derivative Liability USD 18.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 18.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic and Diluted Share USD/shares -0.14 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.89 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.2 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.89 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.213 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.175 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001628280-24-013786
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.005 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.094 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.012 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 1.40M 2022-10-01 2022-10-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 4.36M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 900,890 2015-12-31 2015 FY 10-K 2016-03-23 0001558370-16-004299
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 1.34M 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 0 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap EquitySecuritiesFvNiGainLoss Equity Securities, FV-NI, Gain (Loss) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap EquitySecuritiesFvNiRealizedGain Equity Securities, FV-NI, Realized Gain USD 5.20M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap EquitySecuritiesFvNiUnrealizedGainLoss Equity Securities, FV-NI, Unrealized Gain (Loss) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap EscrowDeposit Escrow Deposit USD 0 2018-12-31 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2021-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2021-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 7.58M 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001534120-26-000049
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 194.90M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD -6.57M 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001534120-26-000049
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 18.53M 2026-06-30 2026 Q2 10-Q 2026-08-06 0001534120-26-000049
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) USD -1,586 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-07 0001628280-17-010968
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings USD -6.26M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001628280-24-045965
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 5.96M 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 900,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 0 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 1.56M 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 0 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 0 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 0 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 29,159 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 5.96M 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001628280-17-002566
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 23.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap Goodwill Goodwill USD 10.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 3.78M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Impaired, Accumulated Impairment Loss USD 0 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap GoodwillPurchaseAccountingAdjustments Goodwill, Purchase Accounting Adjustments USD -1.66M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 30,135 2017-09-30 2017 Q3 10-Q 2017-11-07 0001628280-17-010968
us-gaap GuaranteeObligationsMaximumExposure Guarantor Obligations, Maximum Exposure, Undiscounted USD 9.00M 2020-06-30 2020 Q2 10-Q 2020-08-06 0001628280-20-011892
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap IncomeLossAttributableToParent Income (Loss) Attributable to Parent, before Tax USD -41.63M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -41.66M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -74.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -35.27M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -1.06 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -4.78M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority USD 400,000 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 36,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 16.66M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -16.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 6,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 353,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 140,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 2.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001628280-24-036591
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD -28,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 102,337 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-07 0001628280-17-010968
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 4.83M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 9.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 645,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD 59,373 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 3.07M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements shares 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 0 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 0 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap InterestExpense Interest Expense USD 634,772 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001558370-15-002671
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 7.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001628280-18-010858
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 46,705 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 382,153 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap InventoryNet Inventory, Net USD 0 2023-12-31 2023 FY 10-K 2024-03-29 0001628280-24-013786
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 0 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 25,371 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap InventoryWriteDown Inventory Write-down USD 36,577 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.105 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 157,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2025-06-30 2025 Q2 10-Q 2025-08-07 0001628280-25-038575
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 63,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 0 2025-06-30 2025 Q2 10-Q 2025-08-07 0001628280-25-038575
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 0 2025-06-30 2025 Q2 10-Q 2025-08-07 0001628280-25-038575
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 0 2025-06-30 2025 Q2 10-Q 2025-08-07 0001628280-25-038575
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 63,000 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 94,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap Liabilities Liabilities USD 44.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 481.43M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap LiabilitiesCurrent Liabilities, Current USD 24.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims USD 500,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 25.00M 2017-08-14 2018 Q2 10-Q 2018-08-09 0001628280-18-010858
us-gaap LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party USD 900,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001628280-20-016113
us-gaap LoansAndLeasesReceivableNetReportedAmount Loans and Leases Receivable, Net Amount USD 4.10M 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap LoansReceivableWithFixedRatesOfInterest1 Loans Receivable with Fixed Rates of Interest USD 5.00M 2019-12-05 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap LongTermDebt Long-term Debt USD 15.38M 2018-03-31 2018 Q1 10-Q 2018-05-11 0001628280-18-006658
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 1.05M 2019-09-30 2019 Q3 10-Q 2019-11-14 0001628280-19-014207
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 14.25M 2019-09-30 2019 Q3 10-Q 2019-11-14 0001628280-19-014207
us-gaap LongTermInvestments Long-term Investments USD 69.81M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-03-29 0001628280-24-013786
us-gaap MinorityInterestOwnershipPercentageByNoncontrollingOwners Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners pure 0.1 2017-10-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 414.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 3.73M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-07 0001628280-17-010968
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -315.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -7,990 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-07 0001628280-17-010968
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -49.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 15.11M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-07 0001628280-17-010968
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -74.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -74.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -74.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 919,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap NotesPayable Notes Payable USD 33.18M 2022-03-31 2022 Q1 10-Q 2022-05-05 0001628280-22-012436
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-29 0001628280-24-013786
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap NumberOfReportingUnits Number of Reporting Units reportingUnit 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap OperatingExpenses Operating Expenses USD 32.19M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001628280-19-014207
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -75.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap OperatingLeaseCost Operating Lease, Cost USD 217,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 153,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 153,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap OperatingLeasePayments Operating Lease, Payments USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 126,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 1.86M 2018-09-30 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 0 2018-09-30 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 178,092 2018-09-30 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 173,748 2018-09-30 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 169,510 2018-09-30 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 155,815 2018-09-30 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 1.18M 2018-09-30 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 39,433 2017-09-30 2017 Q3 10-Q 2017-11-07 0001628280-17-010968
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 239,259 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 52.20M 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 0 2023-12-31 2023 FY 10-K 2024-03-29 0001628280-24-013786
us-gaap OtherCommitment Other Commitment USD 5.25M 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap OtherCommitmentDueInFifthYear Other Commitment, to be Paid, Year Five USD 0 2018-09-30 2018 Q3 10-Q 2018-11-13 0001628280-18-014190
us-gaap OtherCommitmentDueInFourthYear Other Commitment, to be Paid, Year Four USD 0 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap OtherCommitmentDueInNextTwelveMonths Other Commitment, to be Paid, Year One USD 3.00M 2018-12-31 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap OtherCommitmentDueInSecondYear Other Commitment, to be Paid, Year Two USD 3.00M 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap OtherCommitmentDueInThirdYear Other Commitment, to be Paid, Year Three USD 0 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear Other Commitment, to be Paid, Remainder of Fiscal Year USD 2.25M 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -1.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -1.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap OtherDeferredCostsNet Other Deferred Costs, Net USD 1.88M 2015-09-30 2015 Q3 10-Q 2015-11-13 0001558370-15-002671
us-gaap OtherIncome Other Income USD 446,897 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001628280-20-016113
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -8,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001534120-25-000018
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001628280-20-006935
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 611,000 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap PaymentForContingentConsiderationLiabilityOperatingActivities Payment for Contingent Consideration Liability, Operating Activities USD 4.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap PaymentsForCapitalImprovements Payments for Capital Improvements USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 26.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap PaymentsForRepurchaseOfPrivatePlacement Payments for Repurchase of Private Placement USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap PaymentsForRepurchaseOfWarrants Payments for Repurchase of Warrants USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 462,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 779,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap PaymentsToAcquireLoansReceivable Payments to Acquire Loans Receivable USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap PaymentsToAcquireOtherPropertyPlantAndEquipment Payments to Acquire Other Property, Plant, and Equipment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001628280-24-013786
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 95,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 428.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 1 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-23 0001558370-16-004299
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2021-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2021-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2021-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 7.56M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap PriorPeriodReclassificationAdjustment Prior Period Reclassification Adjustment USD 400,000 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-14 0001628280-19-014207
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 2.25M 2014-01-01 2014-09-30 2015 Q3 10-Q 2015-11-13 0001558370-15-002671
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap ProceedsFromDivestitureOfBusinessesNetOfCashDivested Proceeds from Divestiture of Businesses, Net of Cash Divested USD 12.84M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001628280-20-016113
us-gaap ProceedsFromIncomeTaxRefunds Proceeds from Income Tax Refunds USD 500,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 405.00M 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001534120-26-000049
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 14.76M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001628280-17-002566
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 4.40M 2021-01-01 2021-01-31 2022 Q1 10-Q 2022-05-05 0001628280-22-012436
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001628280-17-002566
us-gaap ProceedsFromLicenseFeesReceived Proceeds from License Fees Received USD 19.50M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 32.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 112.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 400,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0001628280-23-015703
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 9.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 66,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 718,675 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.71M 2020-09-30 2020 Q3 10-Q 2020-11-09 0001628280-20-016113
us-gaap PurchaseObligation Purchase Obligation USD 2.21M 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap PurchaseObligationDueInFifthYear Purchase Obligation, to be Paid, Year Five USD 0 2018-09-30 2018 Q3 10-Q 2018-11-13 0001628280-18-014190
us-gaap PurchaseObligationDueInFourthYear Purchase Obligation, to be Paid, Year Four USD 0 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 1.26M 2018-12-31 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap PurchaseObligationDueInSecondYear Purchase Obligation, to be Paid, Year Two USD 1.27M 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap PurchaseObligationDueInThirdYear Purchase Obligation, to be Paid, Year Three USD 0 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear Purchase Obligation, to be Paid, Remainder of Fiscal Year USD 942,994 2019-03-31 2019 Q1 10-Q 2019-05-09 0001628280-19-006439
us-gaap RepaymentsOfDebt Repayments of Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 2.50M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001628280-21-010083
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 52.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 100,000 2017-12-31 2018 FY 10-K 2019-03-18 0001628280-19-003078
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 211,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 183,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -523.46M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 59,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001628280-18-006658
us-gaap Revenues Revenues USD 4.48M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001628280-18-006658
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 72.00M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 22.90M 2026-05-07 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 5.5 2019-03-08 2020 Q1 10-Q 2020-05-07 0001628280-20-006935
us-gaap SalesDiscountsGoods Sales Discounts, Goods (Deprecated 2018-01-31) USD 57,705 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 4.26M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001628280-18-006658
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 1.90M 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-04 0001628280-23-015703
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 10.30M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001628280-24-013786
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 14.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001628280-22-012436
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001628280-22-012436
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001534120-26-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.7 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-14 0001628280-17-002566
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 243,228 2022-06-30 2022 Q2 10-Q 2022-08-04 0001628280-22-020866
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.76M 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 5.02 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 6.50M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001534120-26-000049
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 46,247 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.02M 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.66 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 36.60M 2026-06-30 2026 Q2 10-Q 2026-08-06 0001534120-26-000049
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.82M 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.93 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 12.00M 2026-06-30 2026 Q2 10-Q 2026-08-06 0001534120-26-000049
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2020-12-31 2020 FY 10-K 2021-03-08 0001628280-21-004162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 2.82M 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 3.93 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 2.90M 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 997,902 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 2.98 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 3.57 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.94 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap SharePrice Share Price USD/shares 9.5 2024-09-30 2024 Q3 10-Q 2024-11-07 0001628280-24-045965
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 6,969 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001628280-19-014207
us-gaap ShortTermInvestments Short-term Investments USD 327.98M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 436.55M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.004 2023-12-28 2024 Q3 10-Q 2024-11-07 0001628280-24-045965
us-gaap StockIssued1 Stock Issued USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 172,500 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001628280-19-014207
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 15.50M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-02 0001628280-22-004671
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 1,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 66,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 404.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 37.65M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 1.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD -779,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 9.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 3.64M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-20 0001628280-25-013986
us-gaap TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) USD 2.20M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 3.23M 2017-09-30 2017 Q3 10-Q 2017-11-07 0001628280-17-010968
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap TemporaryEquityDividendsAdjustment Temporary Equity, Dividends, Adjustment USD 81,964 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-23 0001558370-16-004299
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2025-09-30 2025 Q3 10-Q 2025-11-06 0001534120-25-000018
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 5.00M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001534120-25-000018
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic Undistributed Continuing Operation Earnings (Loss), Allocation to Participating Securities, Basic USD -36.93M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap UndistributedDiscontinuedOperationEarningsLossAllocationToParticipatingSecuritiesBasic Undistributed Discontinued Operation Earnings (Loss), Allocation to Participating Securities, Basic USD -4.78M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 177,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-06 0001534120-25-000018
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2016-12-31 2016 FY 10-K 2017-03-14 0001628280-17-002566
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2017-12-31 2017 FY 10-K 2018-04-02 0001628280-18-003890
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-14 0001628280-17-002566
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 4.60M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001628280-24-013786
us-gaap WarrantExercisePriceIncrease Warrant, Exercise Price, Increase USD/shares 5 2023-02-07 2023 Q1 10-Q 2023-05-04 0001628280-23-015703
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 4.05M 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-06 0001534120-25-000018
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 39.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 34.77M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001628280-20-003395
us-gaap WeightedAverageNumberOfSharesContingentlyIssuable Weighted Average Number of Shares, Contingently Issuable shares 139,747 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009630
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 39.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001534120-26-000057

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →